NewAmsterdam Pharma N.V. (NAMS)
21.47
-1.14 (-5.04%)
At close: Jan 28, 2025, 2:55 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 |
| PE Ratio | -5.19 | -9.78 | -4.71 | -32.77 |
| PS Ratio | 71.91 | 2.16 | n/a | n/a |
| PB Ratio | 3.18 | 0.43 | 3.48 | -52.66 |
| P/FCF Ratio | -6.5 | 25.97 | -6.87 | -31.48 |
| P/OCF Ratio | -6.5 | 25.93 | -6.88 | -31.55 |
| OCF/S Ratio | -11.06 | 0.08 | n/a | n/a |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | -3.26 |
| Quick Ratio | 6.95 | 12.64 | 5.96 | 0.72 |
| Current Ratio | 6.95 | 12.64 | 5.96 | 0.72 |
| Asset Turnover | 0.04 | 0.18 | n/a | n/a |
| Interest Coverage | -24.38 | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.61 | -0.04 | -0.74 | 1.61 |
| Return on Assets (ROA) | -0.51 | -0.04 | -0.61 | -0.62 |
| Return on Capital (ROIC) | -0.56 | -0.01 | -0.62 | 1.52 |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 100.00% | n/a | n/a |
| Net Profit Margin | -1.39K% | -22.04% | n/a | n/a |
| Pretax Profit Margin | -1.26K% | -22.04% | n/a | n/a |
| Operating Profit Margin | -1.30K% | -3.46% | n/a | n/a |
| FCF Margin | -1.11K% | 8.30% | n/a | n/a |
| EBITDA Margin | -1.39K% | -3.45% | n/a | n/a |